Safety and Preliminary Efficacy of Aleeto in Amyotrophic Lateral Sclerosis

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 15, 2023

Primary Completion Date

October 30, 2024

Study Completion Date

October 30, 2024

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DRUG

Aleeto

According to the groups, patients would be treated with Aleeto via intrathecal injection or intravenous injection, and the specific dosage and administration method of Aleeto will depend on the grouping.

DEVICE

intravenous injection

According to the groups, patients would be treated with Aleeto or placebo +100ml sodium chloride injection via intravenous injection, depend on the grouping

DEVICE

intrathecal injection

According to the groups, patients would be treated with Aleeto or placebo + 8ml sodium chloride injection via intrathecal injection, depend on the grouping.

Trial Locations (1)

100050

Beijing Tiantan Hospital, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER